Home » EPIC Archives: AVCT (page 3)

AVCT News Archives

What is an Affimer?

Avacta Group Plc

Affimer reagents and therapeutics are a class of non-antibody binding proteins that have been engineered for a wide range of applications where antibodies and aptamers have limitations. They can be ...

Read Article »

The Next Wave of Immuno-Oncology

Avacta Group Plc

In 2017, the first immuno-oncology cell therapies, known as chimeric antigen receptor T cells, or CAR T, were approved by the U.S. Food and Drug Administration. Immuno-oncology cell therapy is ...

Read Article »